Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Tao

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Journal of Medicinal Chemistry|December 3, 2013
Synthesis and biological evaluation of α-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albuminBen-Tao Yin, Cong-Yan Yan, Xin-Mei Peng, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|February 9, 2026
Prelacrimal Recess-Pterygoid Window Approach to the Sphenoidal Lateral Recess Skull Base DefectsZhen-Xiao Huang, Bing Zhou, Jing-Ying Ma, et al.
Zhonghua Yi Xue Za Zhi|June 15, 2007
[Identification of gene expression patterns in superficial and invasive human bladder cancers]Liang Zhou, Ben-tao Shi, Sheng-xing Wang, et al.
Journal of the American College of Cardiology|November 3, 2022
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac DiseaseMichael A Portman, Jeffrey P Jacobs, Jane W Newburger, et al.
International Journal of Ophthalmology|September 19, 2024
Bone destruction of orbital wall in idiopathic orbital inflammatory pseudotumor: does it always imply malignancy?Qi-Han Guo, Xuan Zhang, An-Qi Huang, et al.
Clinical Pharmacology in Drug Development|May 14, 2025
Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open-Label, Phase I StudyMasaya Tachibana, Thuy Vu Craveiro, Thomas C Marbury, et al.
Clinical and Translational Science|January 12, 2022
Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS-1211, a tissue-nonspecific alkaline phosphatase inhibitorSonomi Maruyama, Hester Visser, Takashi Ito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Journal of Medicinal Chemistry|December 3, 2013
Synthesis and biological evaluation of α-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albuminBen-Tao Yin, Cong-Yan Yan, Xin-Mei Peng, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|February 9, 2026
Prelacrimal Recess-Pterygoid Window Approach to the Sphenoidal Lateral Recess Skull Base DefectsZhen-Xiao Huang, Bing Zhou, Jing-Ying Ma, et al.
Zhonghua Yi Xue Za Zhi|June 15, 2007
[Identification of gene expression patterns in superficial and invasive human bladder cancers]Liang Zhou, Ben-tao Shi, Sheng-xing Wang, et al.
Journal of the American College of Cardiology|November 3, 2022
Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac DiseaseMichael A Portman, Jeffrey P Jacobs, Jane W Newburger, et al.
International Journal of Ophthalmology|September 19, 2024
Bone destruction of orbital wall in idiopathic orbital inflammatory pseudotumor: does it always imply malignancy?Qi-Han Guo, Xuan Zhang, An-Qi Huang, et al.
Clinical Pharmacology in Drug Development|May 14, 2025
Effect of Mild to Moderate Hepatic Impairment on Valemetostat Pharmacokinetics: An Open-Label, Phase I StudyMasaya Tachibana, Thuy Vu Craveiro, Thomas C Marbury, et al.
Clinical and Translational Science|January 12, 2022
Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS-1211, a tissue-nonspecific alkaline phosphatase inhibitorSonomi Maruyama, Hester Visser, Takashi Ito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.
Pageof 3